Wednesday, May 18, 2011

Cancer Cure Not Profitable Enough to Approve

A simple, cheap chemical called dichloroacetate (DHC) has showed promising results in killing most types of cancer cells by disrupting the way they process sugar.  The chemical is too widely used to patent, therefore no major pharmaceutical company is willing front the $500+ million investment needed for clinical trials.

We've reached the point where the progress of modern medicine and capitalism are at odds.  Fortunately, the treatment is available in Canada.  We'll just have to wait until some of our billionaires get cancer before it is explored in the US.   

No comments:

Post a Comment